Ragosa Mark
SEC insider (Form 3/4/5 filer). CIK 0001835458. CHIEF FINANCIAL OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA). 94 reported Form 4/5 transactions since Sep 2024; latest on Sep 1, 2026. Located in LONDON.
Companies Ragosa Mark has filed insider reports for
- Kiniksa Pharmaceuticals International, plc (KNSA): Officer, CHIEF FINANCIAL OFFICER
Ragosa Mark
CIK: 0001835458
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Kiniksa Pharmaceuticals International, plc
Discretionary Trading P&L
Holdings
Transaction History (94 total)
- Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect1.8K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect1.6K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectShare Option
31.2K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectRestricted Share Unit
7.8K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
Tax PaymentDirect4.4K shares at avg. $79.28$349K - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect3.1K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.7K shares- - Apr 7, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.7K shares- - Apr 7, 2026KNSA
Kiniksa Pharmaceuticals International, plc
Tax PaymentDirect1.3K shares at avg. $48.94$64K - Apr 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect5.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 1,750 | - | $0 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 1,591 | - | $0 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Share Option | 31,150 | - | - | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Restricted Share Unit | 7,800 | - | - | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Tax Payment | 4,404 | $79.28 | $349,149 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 3,069 | - | $0 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,694 | - | $0 | Direct |
| Apr 7, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,694 | - | $0 | Direct |
| Apr 7, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Tax Payment | 1,303 | $48.94 | $63,769 | Direct |
| Apr 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 5,187 | - | $0 | Direct |
1-10 of 94 transactions